Clinical trial
Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer
NCT02592317 is registered in ClinicalTrials.gov with Aragon Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug-drug Interaction Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Subjects With Castration-Resistant Prostate Cancer
- Lead sponsor
- Aragon Pharmaceuticals, Inc.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- February 12, 2016
- Completion date
- December 31, 2027
- Enrollment
- 23 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.